Two Innovative skincare products – Cahaya Naturals Multi Protect Sunscreen Gel and Cahaya Naturals Pure Neem Face Wash was launched by Cadila Pharmaceuticals
Ahmedabad: Cadila Pharmaceuticals, one of the largest and oldest privately held drug manufacturers in the country, has unveiled two cutting-edge skincare products for the Indian market, showcasing its commitment to elevating skincare and enhancing overall well-being.
The first innovative product is the Cahaya Naturals Multi Protect Sunscreen Gel, a transparent and non-greasy gel that is the ultimate defence against harmful UV rays and blue light with a super high SPF 50 PA++++ protection level. Infused with soothing aloe vera extract, the gel caters to all skin types, offering quick absorption, hydration, and water & sweat resistance. Its other benefits include broad-spectrum protection and a non-greasy texture.
The second innovative skincare product is the Cahaya Naturals Pure Neem Face Wash, a rejuvenating face wash that revitalises dry and dull skin, leaving it soft and well-hydrated. It is infused with natural foaming ingredients, which help in deep cleansing, improving skin texture, and maintaining the skin’s pH balance. Comprising 80% purified water and filled with plant-based natural surfactants, the face wash helps keep the skin moisturised. It is also enriched with aloe vera and Vitamin E, refreshing and revitalising the skin, making it an ideal choice for achieving glowing skin.
“Skincare has become extremely challenging due to extreme heat conditions, worsened by high pollution levels, and lifestyle changes. These two pioneering skincare essentials reflect Cadila Pharmaceuticals’ commitment to promoting health and beauty. Many more products aimed at enhancing skin health care in the pipeline and will be launched soon,” said Ms Vandana Modi, Vice President of Cadila Pharmaceuticals’ Herbal Division.
About Cadila Pharmaceuticals Limited
Cadila Pharmaceuticals Ltd. is one of India’s leading integrated privately held pharmaceutical firms, located in Ahmedabad, Gujarat. The firm develops and produces pharmaceutical products in India and sells and distributes them in over 100 countries. The organization places a high priority on research, whether it is in biotechnology, APIs, formulations, plant tissue culture or phytochemistry to innovate in various therapeutic areas including gastrointestinal, cardiology, pulmonary, oncology, gynaecology, cardiovascular, Diabetology, and osteology. Its commitment to create affordable miracles in therapeutic areas with significant unmet medical needs has led to several world-first breakthroughs.
